TRAX
First Tracks Biotherapeutics
$42.03
+$6.51 (+18.33%)Jul 27, 2026
Key metrics
The numbers that frame TRAX today
- Market cap
- $1.47B
- Div yield
- 0%
- Debt / equity
- 0.0
Growth
Revenue and earnings trend for TRAX
RevenueNet income
See the full growth breakdown
Revenue and earnings trends, margins and the multi-year trajectory - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inCash flow & returns
Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture
Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inInsider trading
Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade
See who is buying and selling, how much, and when - updated as new filings land.
Create a free accountFree foreverNo card required
Already a member? Log inFrequently asked questions
Plain-English answers about TRAX
Is First Tracks Biotherapeutics a good buy?
Hold. There is not enough rank data to make a clear call.
What is the market capitalization of TRAX?
First Tracks Biotherapeutics's market capitalization is $1.47B.
Does TRAX stock pay dividends?
First Tracks Biotherapeutics does not currently show a dividend per share in the company data.
What is the Debt / Equity ratio for TRAX?
First Tracks Biotherapeutics's Debt / Equity ratio is 0.